Accuracy and usability of the eGVHD app in assessing the severity of graft-versus-host disease at the 2017 EBMT annual congress

Affiliations

• ¹ Department of Hematology, University Hospital Leuven and KU Leuven, Leuven, Belgium. helene.schoemans@uzleuven.be.
• ² Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium. helene.schoemans@uzleuven.be.
• ³ Department of Hematology, University Hospital Leuven and KU Leuven, Leuven, Belgium.
• ⁴ Department of Information Technology, University Hospital Leuven, Leuven, Belgium.
• ⁵ KU Leuven - University of Leuven and Universiteit Hasselt, I-Biostat, Leuven, Belgium.
• ⁶ Academic Centre for Nursing and Midwifery, KU Leuven, Leuven, Belgium.
• ⁷ Institute of Nursing Science, Department of Public Health, University of Basel, Basel, Switzerland.
• ⁸ Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
• ⁹ Division of Hematology, Medical University of Graz, Graz, Austria.
• ¹⁰ Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.
• ¹¹ Center for Cancer Research National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
• ¹² Division of Hematology/Oncology, University of Pittsburgh Cancer Institute/UPMC Hillman Cancer Center, Pittsburgh, PA, USA.
• ¹³ Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
• ¹⁴ Department of Hematology, Oncology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland.
• ¹⁵ Department of Hematology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.